FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1996982788> ?p ?o ?g. }

• W1996982788 endingPage "1213" @default.
• W1996982788 startingPage "1213" @default.
• W1996982788 abstract "<h3>Objectives</h3> To determine the clinical effect of oral montelukast sodium, a leukotriene receptor antagonist, in asthmatic patients aged 15 years or more. <h3>Design</h3> Randomized, multicenter, double-blind, placebo-controlled, parallel-group study. A 2-week, single-blind, placebo run-in period was followed by a 12-week, double-blind treatment period (montelukast sodium, 10 mg, or matching placebo, once daily at bedtime) and a 3-week, double-blind, washout period. <h3>Setting/Patients</h3> Fifty clinical centers randomly allocated 681 patients with chronic, stable asthma to receive placebo or montelukast after demonstrating a forced expiratory volume in 1 second 50% to 85% of the predicted value, at least a 15% improvement in forced expiratory volume in 1 second (absolute value) after inhaled β-agonist administration, a minimal predefined level of daytime asthma symptoms, and inhaled β-agonist use. Twenty-three percent of the patients used concomitant inhaled corticosteroids. <h3>Primary End Points</h3> Forced expiratory volume in 1 second and daytime asthma symptoms. <h3>Results</h3> Montelukast improved airway obstruction (forced expiratory volume in 1 second, morning and evening peak expiratory flow rate) and patient-reported end points (daytime asthma symptoms, as-needed β-agonist use, nocturnal awakenings) (<i>P</i><.001 compared with placebo). Montelukast provided near-maximal effect in these end points within the first day of treatment. Tolerance and rebound worsening of asthma did not occur. Montelukast improved outcome end points, including asthma exacerbations, asthma control days (<i>P</i><.001 compared with placebo), and decreased peripheral blood eosinophil counts (<i>P</i><.001 compared with placebo). The incidence of adverse events and discontinuations from therapy were similar in the montelukast and placebo groups. <h3>Conclusions</h3> Montelukast, compared with placebo, significantly improved asthma control during a 12-week treatment period. Montelukast was generally well tolerated, with an adverse event profile comparable with that of placebo." @default.
• W1996982788 created "2016-06-24" @default.
• W1996982788 creator A5014182109 @default.
• W1996982788 creator A5038091130 @default.
• W1996982788 creator A5041514981 @default.
• W1996982788 creator A5075475431 @default.
• W1996982788 creator A5081715180 @default.
• W1996982788 creator A5088953706 @default.
• W1996982788 date "1998-06-08" @default.
• W1996982788 modified "2023-09-27" @default.
• W1996982788 title "Montelukast, a Once-Daily Leukotriene Receptor Antagonist, in the Treatment of Chronic Asthma<subtitle>A Multicenter, Randomized, Double-blind Trial</subtitle>" @default.
• W1996982788 cites W1851252 @default.
• W1996982788 cites W1909409123 @default.
• W1996982788 cites W1964069534 @default.
• W1996982788 cites W1971569966 @default.
• W1996982788 cites W1980657378 @default.
• W1996982788 cites W1990024821 @default.
• W1996982788 cites W2014608611 @default.
• W1996982788 cites W2023071459 @default.
• W1996982788 cites W2031512307 @default.
• W1996982788 cites W2041017243 @default.
• W1996982788 cites W2042420210 @default.
• W1996982788 cites W2052828945 @default.
• W1996982788 cites W2073802634 @default.
• W1996982788 cites W2083950184 @default.
• W1996982788 cites W2086167722 @default.
• W1996982788 cites W2104505088 @default.
• W1996982788 cites W2105573753 @default.
• W1996982788 cites W2105665234 @default.
• W1996982788 cites W2108702725 @default.
• W1996982788 cites W2120012059 @default.
• W1996982788 cites W2126699335 @default.
• W1996982788 cites W2159460969 @default.
• W1996982788 cites W2160851493 @default.
• W1996982788 cites W2166915910 @default.
• W1996982788 cites W2401870479 @default.
• W1996982788 cites W2604596332 @default.
• W1996982788 cites W2776652726 @default.
• W1996982788 doi "https://doi.org/10.1001/archinte.158.11.1213" @default.
• W1996982788 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9625400" @default.
• W1996982788 hasPublicationYear "1998" @default.
• W1996982788 type Work @default.
• W1996982788 sameAs 1996982788 @default.
• W1996982788 citedByCount "465" @default.
• W1996982788 countsByYear W19969827882012 @default.
• W1996982788 countsByYear W19969827882013 @default.
• W1996982788 countsByYear W19969827882014 @default.
• W1996982788 countsByYear W19969827882015 @default.
• W1996982788 countsByYear W19969827882016 @default.
• W1996982788 countsByYear W19969827882017 @default.
• W1996982788 countsByYear W19969827882018 @default.
• W1996982788 countsByYear W19969827882019 @default.
• W1996982788 countsByYear W19969827882020 @default.
• W1996982788 countsByYear W19969827882021 @default.
• W1996982788 countsByYear W19969827882022 @default.
• W1996982788 countsByYear W19969827882023 @default.
• W1996982788 crossrefType "journal-article" @default.
• W1996982788 hasAuthorship W1996982788A5014182109 @default.
• W1996982788 hasAuthorship W1996982788A5038091130 @default.
• W1996982788 hasAuthorship W1996982788A5041514981 @default.
• W1996982788 hasAuthorship W1996982788A5075475431 @default.
• W1996982788 hasAuthorship W1996982788A5081715180 @default.
• W1996982788 hasAuthorship W1996982788A5088953706 @default.
• W1996982788 hasConcept C126322002 @default.
• W1996982788 hasConcept C142724271 @default.
• W1996982788 hasConcept C204787440 @default.
• W1996982788 hasConcept C27081682 @default.
• W1996982788 hasConcept C2776042228 @default.
• W1996982788 hasConcept C2776322731 @default.
• W1996982788 hasConcept C42219234 @default.
• W1996982788 hasConcept C71924100 @default.
• W1996982788 hasConceptScore W1996982788C126322002 @default.
• W1996982788 hasConceptScore W1996982788C142724271 @default.
• W1996982788 hasConceptScore W1996982788C204787440 @default.
• W1996982788 hasConceptScore W1996982788C27081682 @default.
• W1996982788 hasConceptScore W1996982788C2776042228 @default.
• W1996982788 hasConceptScore W1996982788C2776322731 @default.
• W1996982788 hasConceptScore W1996982788C42219234 @default.
• W1996982788 hasConceptScore W1996982788C71924100 @default.
• W1996982788 hasIssue "11" @default.
• W1996982788 hasLocation W19969827881 @default.
• W1996982788 hasLocation W19969827882 @default.
• W1996982788 hasOpenAccess W1996982788 @default.
• W1996982788 hasPrimaryLocation W19969827881 @default.
• W1996982788 hasRelatedWork W2018270163 @default.
• W1996982788 hasRelatedWork W2033836503 @default.
• W1996982788 hasRelatedWork W2060952785 @default.
• W1996982788 hasRelatedWork W2118319650 @default.
• W1996982788 hasRelatedWork W2155991787 @default.
• W1996982788 hasRelatedWork W2163521166 @default.
• W1996982788 hasRelatedWork W2607120056 @default.
• W1996982788 hasRelatedWork W2619141725 @default.
• W1996982788 hasRelatedWork W2894848803 @default.
• W1996982788 hasRelatedWork W4322724676 @default.
• W1996982788 hasVolume "158" @default.
• W1996982788 isParatext "false" @default.
• W1996982788 isRetracted "false" @default.
• W1996982788 magId "1996982788" @default.

• next